| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |